FSD Financial Statements From 2010 to 2024
HUGEDelisted Stock | USD 0.09 0 4.56% |
Check FSD Pharma financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among FSD Pharma's main balance sheet or income statement drivers, such as , as well as many indicators such as . FSD financial statements analysis is a perfect complement when working with FSD Pharma Valuation or Volatility modules.
FSD |
FSD Pharma Class Company Current Valuation Analysis
FSD Pharma's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current FSD Pharma Current Valuation | 4.57 M |
Most of FSD Pharma's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, FSD Pharma Class is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
CompetitionIn accordance with the recently published financial statements, FSD Pharma Class has a Current Valuation of 4.57 M. This is 99.97% lower than that of the IT Services sector and significantly higher than that of the Information Technology industry. The current valuation for all United States stocks is 99.97% higher than that of the company.
FSD Pharma Class Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining FSD Pharma's current stock value. Our valuation model uses many indicators to compare FSD Pharma value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across FSD Pharma competition to find correlations between indicators driving FSD Pharma's intrinsic value. More Info.FSD Pharma Class is one of the top stocks in return on equity category among its peers. It also is one of the top stocks in return on asset category among its peers . Comparative valuation analysis is a catch-all technique that is used if you cannot value FSD Pharma by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.About FSD Pharma Financial Statements
FSD Pharma stakeholders use historical fundamental indicators, such as FSD Pharma's revenue or net income, to determine how well the company is positioned to perform in the future. Although FSD Pharma investors may analyze each financial statement separately, they are all interrelated. For example, changes in FSD Pharma's assets and liabilities are reflected in the revenues and expenses on FSD Pharma's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in FSD Pharma Class. Please read more on our technical analysis and fundamental analysis pages.
FSD Pharma Inc., a biotechnology company, operates in the pharmaceutical research and development business. The company is also involved in the research and development of Lucid-Psych, a molecular compound identified for the treatment of mental health disorders and Lucid-MS, a molecular compound identified for the treatment of neurodegenerative disorders. FSD Pharma operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on NASDAQ Exchange. It employs 10 people.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Other Consideration for investing in FSD Stock
If you are still planning to invest in FSD Pharma Class check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the FSD Pharma's history and understand the potential risks before investing.
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals |